首页> 美国卫生研究院文献>Cancer Biology Therapy >PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism
【2h】

PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism

机译:PTEN通过CCL2和VEGF-A还原以及NHERF-1协同作用抑制M1至M2的巨噬细胞极化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PTEN has been studied in several tumor models as a tumor suppressor. In this study, we explored the role of PTEN in the inhibition state of polarized M2 subtype of macrophage in tumor microenvironment (TME) and the underlying mechanisms. To elucidate the potential effect in TME, RAW 264.7 macrophages and 4T1 mouse breast cancer cells were co-cultured to reconstruct tumor microenvironment. After PTEN was down-regulated with shRNA, the expression of CCL2 and VEGF-A, which are definited to promote the formation of M2 macrophages, have a dramatically increase on the level of both gene and protein in co-cultured RAW 264.7 macrophages. And at the same time, NHERF-1 (Na+/H+ exchanger regulating factor-1), another tumor suppressor has a similar tendency to PTEN. Q-PCR and WB results suggested that PTEN and NHERF-1 were consistent with one another no matter at mRNA or protein level when exposed to the same stimulus. Coimmunoprecipitation and immunofluorescence techniques confirmed that PTEN and NHERF-1 were coprecipitated, and NHERF-1 protein expression was properly reduced with rCCL2 effect. In addition, cell immunofluorescence images revealed a profound transferance, in co-cultured RAW 264.7 macrophages, an up-regulation of NHERF-1 could promote the PTEN marked expression on the cell membrane, and this form for the interaction was not negligible. These observations illustrate PTEN with a certain synergy of NHERF-1, as well as down-regulation of CCL2 suppressing M2 macrophage transformation pathway. The results suggest that the activation of PTEN and NHERF-1 may impede the evolution of macrophages beyond the M1 into M2 phenotype in tumor microenvironment.
机译:已经在几种肿瘤模型中研究了PTEN作为肿瘤抑制剂。在这项研究中,我们探讨了PTEN在肿瘤微环境(TME)中巨噬细胞极化M2亚型的抑制状态中的作用及其潜在机制。为了阐明在TME中的潜在作用,将RAW 264.7巨噬细胞和4T1小鼠乳腺癌细胞共培养以重建肿瘤微环境。在用shRNA下调PTEN后,可以促进M2巨噬细胞形成的CCL2和VEGF-A的表达在共培养的RAW 264.7巨噬细胞中的基因和蛋白质水平均显着增加。同时,另一种肿瘤抑制因子NHERF-1(Na + / H + 交换调节因子-1)具有与PTEN类似的趋势。 Q-PCR和WB结果表明,PTEN和NHERF-1在暴露于相同刺激下在mRNA或蛋白质水平上都彼此一致。免疫共沉淀和免疫荧光技术证实了PTEN和NHERF-1是共沉淀的,并通过rCCL2作用适当降低了NHERF-1蛋白的表达。此外,细胞免疫荧光图像显示了深刻的转移,在共培养的RAW 264.7巨噬细胞中,NHERF-1的上调可以促进PTEN标记在细胞膜上的表达,并且这种相互作用的形式不可忽略。这些观察结果说明PTEN与NHERF-1具有一定的协同作用,以及下调CCL2抑制M2巨噬细胞转化途径。结果表明,在肿瘤微环境中,PTEN和NHERF-1的激活可能会阻止巨噬细胞从M1进化为M2表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号